SEARCH

SEARCH BY CITATION

REFERENCES

  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 39833988.
  • Bissell MJ, Kenny PA, Radisky DC. 2005. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 70: 343356.
  • Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730737.
  • Cho RW, Clarke MF. 2008. Recent advances in cancer stem cells. Curr Opin Genet Dev 18: 4853.
  • Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 1015810163.
  • Economist T. 2008. Cancer stem cells: The root of all evil? Economist 388: 8486.
  • Fearon ER, Burke PJ, Schiffer CA, Zehnbauer BA, Vogelstein B. 1986. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med 315: 1524.
  • Fidler IJ, Hart IR. 1982. Biological diversity in metastatic neoplasms: Origins and implications. Science 217: 9981003.
  • Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. 2002. Pathobiology of preoperative chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95: 681695.
  • Glasky AJ, Simon L, Holper JC. 1964. Interferons: Selectivity and specificity of action in cell-free systems. Science 144: 15811583.
  • Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT. 2007. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110: 44274435.
  • Hamburger AW, Salmon SE. 1977. Primary bioassay of human tumor stem cells. Science 197: 461463.
  • Heller M. 2008. The gridlock economy: How too much ownership wrecks markets, stops innovation, and costs lives. New York: Basic Books.
  • Heppner GH. 1993. Cancer cell societies and tumor progression. Stem Cells 11: 199203.
  • Jordan CT, Guzman ML, Noble M. 2006. Cancer stem cells. N Engl J Med 355: 12531261.
  • Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. 2007. Tumor growth need not be driven by rare cancer stem cells. Science 317: 337.
  • Kennedy JA, Barabe F, Poeppl AG, Wang JC, Dick JE. 2007. Comment on “tumor growth need not be driven by rare cancer stem cells”. Science 318: 1722, author reply 1722.
  • Krause DS, Van Etten RA. 2008. Bedside to bench: Interfering with leukemic stem cells. Nat Medicine 14: 494495.
  • Lev S, Blechman J, Nishikawa S, Givol D, Yarden Y. 1993. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Mol Cell Biol 13: 22242234.
  • Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88: 28302834.
  • Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA. 1998. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 18: 33573367.
  • Maillard I, Koch U, Dumortier A, Shestova O, Xu L, Sai H, Pross SE, Aster JC, Bhandoola A, Radtke F, Pear WS. 2008. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2: 356366.
  • Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, Nowak MA. 2005. Dynamics of chronic myeloid leukaemia. Nature 435: 12671270.
  • O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106110.
  • Ohishi K, Varnum-Finney B, Bernstein ID. 2002. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest 110: 11651174.
  • Pardal R, Clarke MF, Morrison SJ. 2003. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895902.
  • Pisano GP. 2006. Science business. Boston, MA: Harvard Business School Press.
  • Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973978.
  • Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. 2008. Efficient tumor formation by single human melanoma cells. Nature 456: 593598.
  • Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE. 1978. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 298: 13211327.
  • Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH. 2008. Identification of cells initiating human melanomas. Nature 451: 345349.
  • Shanafelt AB, Johnson KE, Kastelein RA. 1991. Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificity. J Biol Chem 266: 1380413810.
  • Shipitsin M, Polyak K. 2008. The cancer stem cell hypothesis: In search of definitions, markers, and relevance. Lab Invest 88: 459463.
  • Skipper HE. 1986. On mathematical modeling of critical variables in cancer treatment goals: Better understanding of the past and better planning in the future. Bull Math Biol 48: 253278.
  • van Dam M, Mullberg J, Schooltink H, Stoyan T, Brakenhoff JP, Graeve L, Heinrich PC, Rose-John S. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J Biol Chem 268: 1528515290.
  • Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G. 2006. Models for facilitating access to patents on genetic inventions. Nat Rev Genet 7: 143148.
  • Virchow R. 1860. Cellular pathology. London: John Churchill.
  • Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R, Jackson TL, Gaiano N, Oliver T, Reya T. 2007. Imaging hematopoietic precursor division in real time. Cell Stem Cell 1: 541554.
  • Zucchi I, Sanzone S, Astigiano S, Pelucchi P, Scotti M, Valsecchi V, Barbieri O, Bertoli G, Albertini A, Reinbold RA, Dulbecco R. 2007. The properties of a mammary gland cancer stem cell. Proc Natl Acad Sci USA 104: 1047610481.